(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO

January 04, 2021

Enzon Pharmaceuticals Announces Results of Rights Offering

October 21, 2020

Looking to Next Step – Acquisition Opportunities

Performance

More News

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

September 15, 2020

Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting

September 02, 2020

Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

August 21, 2020

Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value

August 14, 2020

Independent Research on Trending Growth Companies: Vet Online Supply and Enzon Pharmaceuticals

March 05, 2018

OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX

August 09, 2016

Biotechnology Stocks Technical Study -- Exelixis, XOMA Corp., Enzon Pharma, Peregrine Pharma, and StemCells

September 21, 2015

Guidance & Quarterly Review on Four Biotech Companies

August 14, 2015

Technical Coverage on Biotechnology Equities -- Achillion Pharma, CTI BioPharma, Enzon Pharma, Discovery Laboratories, and Pacific Biosciences of California

July 20, 2015

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.